共 50 条
- [1] Pharmacokinetics, tolerability and biologic activity of oral Pyridorin™, a novel AGE inhibitor, in patients with type 1 diabetes and diabetic nephropathy. [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 652A - 652A
- [2] Pyridorin in Type 2 Diabetic Nephropathy [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (01): : 131 - 136
- [3] Mechanism of action of Pyridorin™ (pyridoxamine), a novel therapeutic for diabetic complications. [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 535A - 535A
- [9] Novel mechanisms and therapeutic options in diabetic nephropathy [J]. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (04): : 261 - 263
- [10] Myokines: Novel therapeutic targets for diabetic nephropathy [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13